• NextCure Raises $93 Million in Series B Financing firstwordpharma
    November 14, 2018
    BELTSVILLE, Md.--(BUSINESS WIRE)-- NextCure Inc., a privately-held biopharmaceutical company discovering and developing the next generation of immunomedicines for cancer
PharmaSources Customer Service